The recent reauthorization of the Patient-Centered Outcomes Research Institute (PCORI) comes with an expanded mandate to study the economic impacts of treatments presenting new opportunities for the value assessment research community.
T. Joseph Mattingly II, PhD, PharmD, MBA
Advertisement
Articles by T. Joseph Mattingly II, PhD, PharmD, MBA
Advertisement
Latest Updated Articles
PCORI’s Expanded Mandate Creates New Opportunities for Value Assessment ResearchPublished: July 29th 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Physician Peer Influence Drives Uptake of Opportunistic Salpingectomy for Ovarian Cancer Prevention
2
CAR T-Cell Therapy Holds Potential in SCLC, but Significant Barriers Remain
3
Value-Based Care Interventions and Management of CKD Progression
4
Defining the Role of Rilzabrutinib in ITP Management
5
